×
About 27,616 results

ALLMedicine Atopic Dermatitis Center

Research & Reviews  12,113 results

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatiti...
https://doi.org/10.1001/jamadermatol.2020.1406
JAMA Dermatology; Silverberg JI, Simpson EL et. al.

Jun 3rd, 2020 - Abrocitinib, an oral, once-daily Janus kinase 1 selective inhibitor, was effective and well tolerated in a phase 3 monotherapy trial of patients with moderate-to-severe atopic dermatitis (AD). To investigate the efficacy and safety of abrocitinib ...

Long-term effectiveness and safety of treatment with dupilumab in patients with atopic ...
https://doi.org/10.1016/j.jaad.2020.05.128
Journal of the American Academy of Dermatology; Bosma AL, de Wijs LEM et. al.

Jun 2nd, 2020 - Evidence on long-term dupilumab treatment for atopic dermatitis in daily practice is lacking. To investigate patient characteristics, treatment aspects, effectiveness and safety of up to 84 weeks of dupilumab treatment. An observational prospectiv...

Studies of royal jelly and associated cross-reactive allergens in atopic dermatitis pat...
https://doi.org/10.1371/journal.pone.0233707
PloS One; Hata T, Furusawa-Horie T et. al.

Jun 2nd, 2020 - Royal jelly (RJ), a creamy substance secreted by honeybees, is the exclusive diet for queen bee differentiation and life maintenance. RJ has been used in cosmetics, beverages, medicines, and supplements worldwide. However, allergy is a concerning ...

The importance of immunity in the development of reliable animal models for psoriasis a...
https://doi.org/10.1111/imcb.12365
Immunology and Cell Biology; Guerrero-Aspizua S, Carretero M et. al.

Jun 1st, 2020 - Psoriasis (PS) and atopic dermatitis (AD) are common inflammatory skin diseases characterized by an imbalance in specific T cell subsets, resulting in a specific cytokine profile in patients. Obtaining models closely resembling both pathologies is...

One-year real-world clinical effectiveness, safety and laboratory safety of dupilumab i...
https://doi.org/10.1016/j.jaad.2020.05.102
Journal of the American Academy of Dermatology; Uchida H, Kamata M et. al.

Jun 1st, 2020 - One-year real-world clinical effectiveness, safety and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: A single-center retrospective study.|2020|Uchida H,Kamata M,Kato A,Mizukawa I,Watanabe A,|

see more →

Guidelines  25 results

European task force on atopic dermatitis position paper: treatment of parental atopic d...
https://doi.org/10.1111/jdv.15709
Journal of the European Academy of Dermatology and Venereology : JEADV References; Vestergaard C, Wollenberg A et. al.

Jun 24th, 2019 - Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the trea...

Atopic dermatitis/Eczema | DermNet NZ
https://www.dermnetnz.org/topics/atopic-dermatitis/

Jun 24th, 2019 - Atopic dermatitis is a chronic, itchy skin condition that is very common in children but may occur at any age. It is also known as eczema and atopic eczema and was formerly known as Besnier prurigo. It is the most common form of dermatitis. Atopi...

Eczema - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK538209/
Nemeth,V.,et al

Jun 3rd, 2019 - Eczema, also known as atopic dermatitis, is the most common form of dermatitis. Genetic as well as environmental factors are thought to play a part in the pathogenesis. Eczema is most commonly seen in children but can be seen in adults. People ...

The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing...
https://doi.org/10.1542/peds.2019-0281

Mar 17th, 2019 - This clinical report updates and replaces a 2008 clinical report from the American Academy of Pediatrics, which addressed the roles of maternal and early infant diet on the prevention of atopic disease, including atopic dermatitis, asthma, and foo...

Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) ...
https://doi.org/10.1111/jdv.14891
Journal of the European Academy of Dermatology and Venereology : JEADV; Wollenberg A, Barbarot S et. al.

Apr 20th, 2018 - This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic revi...

see more →

Drugs  577 results see all →

Clinicaltrials.gov  13,327 results

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatiti...
https://doi.org/10.1001/jamadermatol.2020.1406
JAMA Dermatology; Silverberg JI, Simpson EL et. al.

Jun 3rd, 2020 - Abrocitinib, an oral, once-daily Janus kinase 1 selective inhibitor, was effective and well tolerated in a phase 3 monotherapy trial of patients with moderate-to-severe atopic dermatitis (AD). To investigate the efficacy and safety of abrocitinib ...

Long-term effectiveness and safety of treatment with dupilumab in patients with atopic ...
https://doi.org/10.1016/j.jaad.2020.05.128
Journal of the American Academy of Dermatology; Bosma AL, de Wijs LEM et. al.

Jun 2nd, 2020 - Evidence on long-term dupilumab treatment for atopic dermatitis in daily practice is lacking. To investigate patient characteristics, treatment aspects, effectiveness and safety of up to 84 weeks of dupilumab treatment. An observational prospectiv...

Studies of royal jelly and associated cross-reactive allergens in atopic dermatitis pat...
https://doi.org/10.1371/journal.pone.0233707
PloS One; Hata T, Furusawa-Horie T et. al.

Jun 2nd, 2020 - Royal jelly (RJ), a creamy substance secreted by honeybees, is the exclusive diet for queen bee differentiation and life maintenance. RJ has been used in cosmetics, beverages, medicines, and supplements worldwide. However, allergy is a concerning ...

The importance of immunity in the development of reliable animal models for psoriasis a...
https://doi.org/10.1111/imcb.12365
Immunology and Cell Biology; Guerrero-Aspizua S, Carretero M et. al.

Jun 1st, 2020 - Psoriasis (PS) and atopic dermatitis (AD) are common inflammatory skin diseases characterized by an imbalance in specific T cell subsets, resulting in a specific cytokine profile in patients. Obtaining models closely resembling both pathologies is...

One-year real-world clinical effectiveness, safety and laboratory safety of dupilumab i...
https://doi.org/10.1016/j.jaad.2020.05.102
Journal of the American Academy of Dermatology; Uchida H, Kamata M et. al.

Jun 1st, 2020 - One-year real-world clinical effectiveness, safety and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: A single-center retrospective study.|2020|Uchida H,Kamata M,Kato A,Mizukawa I,Watanabe A,|

see more →

News  1,547 results

FDA Approves New Biologic for Atopic Dermatitis in Children
https://www.medscape.com/viewarticle/931219

May 26th, 2020 - The Food and Drug Administration has approved dupilumab for children aged 6-11 years with moderate to severe atopic dermatitis, the manufacturers announced. The new indication is for children "whose disease is not adequately controlled with topica...

Sanofi and Regeneron's Dupixent shows more encouraging results
https://www.reuters.com/article/us-sanofi-regeneron-dupixent/sanofi-and-regenerons-dupixent-shows-more-encouraging-results-idUSKBN21L0K6

Apr 3rd, 2020 - PARIS (Reuters) - Healthcare companies Sanofi and Regeneron announced on Friday more encouraging results for their Dupixent product used to treat severe atopic dermatitis, often commonly known as eczema. The companies said that Dupixent Phase 3 da...

Routinely screen for depression in atopic dermatitis
https://www.mdedge.com/pediatrics/article/220092/atopic-dermatitis/routinely-screen-depression-atopic-dermatitis?channel=53
Bruce Jancin

Apr 2nd, 2020 - Screening for depression in patients with atopic dermatitis is a vital task that’s woefully neglected – and dermatologists aren’t doing any better a job of it than primary care physicians, Jonathan I. Silverberg, MD, PhD, declared in a video prese.

New topicals coming for pediatric atopic dermatitis
https://www.mdedge.com/clinicianreviews/article/219636/atopic-dermatitis/new-topicals-coming-pediatric-atopic-dermatitis?channel=53
Bruce Jancin

Mar 26th, 2020 - LAHAINA, HAWAII – Novel topical medications are in the works that will address the longstanding unmet need for a Food and Drug Administration–approved noncorticosteroid topical for use in pediatric atopic dermatitis, Lawrence F. Eichenfield, MD, r.

Colloidal Oatmeal: Optimal Skin-Directed Care for Atopic Dermatitis
https://www.mdedge.com/pediatrics/article/219464/colloidal-oatmeal-optimal-skin-directed-care-atopic-dermatitis?channel=167

Mar 23rd, 2020 - Click to read. Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that affects approximately 10% of US children.

see more →

Patient Education  27 results see all →